Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 233.12M | 230.77M | 227.56M | 227.56M | 227.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 233.12M | 230.77M | 227.56M | 227.56M | 227.98M |
| Cost of Revenue | 141.81M | 143.16M | 128.12M | 127.68M | 128.65M |
| Gross Profit | 91.32M | 87.61M | 99.44M | 99.88M | 99.33M |
| SG&A Expenses | 115.76M | 112.98M | 105.58M | 106.36M | 107.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.53M | -2.96M | -2.28M | -2.54M | -51.00K |
| Total Operating Expenses | 252.03M | 253.18M | 231.43M | 231.50M | 236.54M |
| Operating Income | -18.91M | -22.41M | -3.87M | -3.94M | -8.56M |
| Income Before Tax | 143.14M | 140.93M | 69.37M | -8.01M | -129.36M |
| Income Tax Expenses | 17.57M | 18.57M | 12.88M | 4.42M | -9.47M |
| Earnings from Continuing Operations | 125.56 | 122.37 | 56.48 | -12.43 | -119.89 |
| Earnings from Discontinued Operations | 46.66M | 7.25M | 7.25M | 7.25M | 7.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 172.23M | 129.62M | 63.73M | -5.18M | -112.64M |
| EBIT | -18.91M | -22.41M | -3.87M | -3.94M | -8.56M |
| EBITDA | 278.50K | -2.99M | 6.61M | 6.38M | 1.69M |
| EPS Basic | 0.35 | 0.29 | 0.15 | 0.01 | -0.22 |
| Normalized Basic EPS | 0.15 | 0.16 | 0.10 | 0.00 | -0.16 |
| EPS Diluted | 0.35 | 0.29 | 0.15 | 0.01 | -0.22 |
| Normalized Diluted EPS | 0.15 | 0.16 | 0.10 | 0.00 | -0.16 |
| Average Basic Shares Outstanding | 2.00B | 1.72B | 1.79B | 1.79B | 1.82B |
| Average Diluted Shares Outstanding | 2.00B | 1.72B | 1.79B | 1.79B | 1.82B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |